Palatin Technologies
PTN
#9923
Rank
A$58.98 M
Marketcap
A$34.64
Share price
4.59%
Change (1 day)
2,128.68%
Change (1 year)

Palatin Technologies (PTN) - Total debt

Total debt on the balance sheet as of March 2025 : A$0.39 Million

According to Palatin Technologies's latest financial reports the company's total debt is A$0.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Palatin Technologies - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-06-30A$0.88 M-43.9%
2023-06-30A$1.57 M-5.74%
2022-06-30A$1.67 M0.15%
2021-06-30A$1.67 M-8.95%
2020-06-30A$1.83 M287.02%
2019-06-30A$0.47 M-94.41%
2018-06-30A$8.48 M-53.86%
2017-06-30A$18.39 M-29.83%
2016-06-30A$26.21 M104.76%
2015-06-30A$12.8 M
2014-06-30N/A-100%
2013-06-30A$0.02 M-47.05%
2012-06-30A$0.04 M-42.75%
2011-06-30A$0.07 M79.47%
2010-06-30A$0.04 M-73.34%
2009-06-30A$0.15 M-62.63%
2008-06-30A$0.4 M-30.76%
2007-06-30A$0.58 M35.93%
2006-06-30A$0.42 M979.83%
2005-06-30A$0.03 M-57.08%
2004-06-30A$0.09 M-76.71%
2003-06-30A$0.39 M
2001-06-30A$0.05 M
1999-06-30A$3.02 M108.66%
1998-06-30A$1.44 M-39.19%
1997-06-30A$2.38 M-42.35%
1996-06-30A$4.13 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
MediciNova
MNOV
A$0.45 M 15.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.64 B 163,274.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.93 B 236,460.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.67 B 171,891.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.98 B 17,464,242.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.31 B 79,074.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$49.15 B 12,444,412.24%๐Ÿ‡ฌ๐Ÿ‡ง UK